Last reviewed · How we verify

NCT05863598

Prevention of Eating Disorders Through Optimization of Protective Factors

Recruiting now NA Last updated 6 March 2025
What this trial tests

NA trial testing Enhancing protective factors in Body Dissatisfaction in 644 participants. Currently enrolling.

Timeline
15 May 2023
Primary endpoint
31 July 2027
31 December 2027

Quick facts

Lead sponsorKarolinska Institutet
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment644
Start date15 May 2023
Primary completion31 July 2027
Estimated completion31 December 2027
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Karolinska Institutet

Who can join

Adults 15 to 20, any sex, with Body Dissatisfaction or Eating Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of thin randomized controlled trial is to investigate the efficacy of a prevention program for reducing the incidence of eating disorders among youth (15-20). We target youth at these ages who experience a subjective sense of body dissatisfaction, and are thus at increased risk of developing an eating disorder. The prevention program is based on improving protective factors such as body appreciation, body image flexibility, intuitive eating, and acceptance. It will be compared to a credible placebo (expressive writing).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Body Dissatisfaction

Currently open trials in the same condition.

Other Karolinska Institutet trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05863598.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing